Evolving standards and future directions for systemic therapies in cervical cancer-Reference-Cited by-同舟云学术

Evolving standards and future directions for systemic therapies in cervical cancer

Published:2024 Issue:2 Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Ang Daniel Jia Ming¹^ORCID,Chan Jack Junjie¹²^ORCID

Affiliation:

1. Division of Medical Oncology, National Cancer Centre Singapore, Singapore.

2. Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e65

Reference46 articles.

1. Cancer statistics for the year 2020: An overview

2. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

3. NCI Press Office. NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival [Internet]. Bethesda, MD. National Cancer Institute. 1999. cited 2023 Dec 13. Available from: http://www.nih.gov/news/pr/feb99/nci-22.htm

4. Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer

5. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between household income and prognosis of patients with cervical adenocarcinoma in the United States: A retrospective cohort study based on the SEER database;European Journal of Surgical Oncology;2024-09

2. Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review;Biomedicines;2024-06-11

3. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States;Cancers;2024-03-06